Addus HomeCare Corporation (ADUS) Market Cap & Valuation Ratios
Addus HomeCare Corporation (ADUS) has a market cap of $2.3B, a trailing P/E of 21.3 and a price-to-sales ratio of 1.5, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ADUSAddus HomeCare CorporationFollow ADUS — free
—
Price chart with a free account
- Market cap
- 2.3B
- P/E TTM
- 21.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Peers
medical care facilities · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| ADUS | 2.3 | 21.3 | 1.5 | 13.6 | 6.8% | +16% | 10% | 10% |
| ACHC | 2.9 | — | 1.5 | — | -4.6% | +4% | -28% | -20% |
| AVAH | 2.9 | — | 1.6 | 15.0 | 5.4% | +20% | 11% | 13% |
| GRDN | 2.5 | 38.7 | 1.6 | 22.1 | 3.0% | +10% | 6% | 38% |
| BKD | 2.4 | — | 2.1 | 14.5 | 0.0% | -4% | 3% | 2% |
| MD | 2.4 | 14.0 | 1.3 | 10.7 | 9.6% | +0.5% | 11% | 14% |
| ASTH | 2.1 | 45.1 | 0.7 | 16.0 | 4.5% | +59% | 3% | 6% |
| SGRY | 2.1 | — | 1.7 | 10.0 | 9.1% | +4% | 11% | 6% |
| AMN | 1.9 | 17.8 | 0.7 | 6.5 | 23.6% | +24% | 6% | 10% |
| ARDT | 1.7 | 22.3 | 0.3 | 5.7 | 17.6% | +3% | 3% | 9% |
| HCSG | 1.7 | 17.1 | 0.8 | 10.6 | 6.3% | +4% | 7% | 28% |
| Median of these 10 | 20.1 | 1.4 | 10.7 | 5.8% | +4% | 6% | 10% |
P/E 21.3 vs. a peer median of 20.1; EV/Sales 1.5 vs. 1.4. ADUS's own P/E sits at the 13th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesACHC and AVAH and BKD and SGRY have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Addus HomeCare Corporation — questions
- What is Addus HomeCare Corporation's market cap?
- $2.3B.
- What is Addus HomeCare Corporation's P/E ratio?
- 21.3 on trailing twelve-month earnings to 2026-06-30.
- What is Addus HomeCare Corporation's price-to-sales ratio?
- 1.5.
Every figure on this page comes from Addus HomeCare Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.